0001209191-18-020020.txt : 20180315 0001209191-18-020020.hdr.sgml : 20180315 20180315200242 ACCESSION NUMBER: 0001209191-18-020020 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180313 FILED AS OF DATE: 20180315 DATE AS OF CHANGE: 20180315 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Varian John CENTRAL INDEX KEY: 0001416176 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33958 FILM NUMBER: 18693929 MAIL ADDRESS: STREET 1: ARYX THERAPEUTICS,INC. STREET 2: 6300 DUMBARTON CIRCLE CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SELLAS Life Sciences Group, Inc. CENTRAL INDEX KEY: 0001390478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 315 MADISON AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (813) 864-4523 MAIL ADDRESS: STREET 1: 315 MADISON AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: Galena Biopharma, Inc. DATE OF NAME CHANGE: 20110926 FORMER COMPANY: FORMER CONFORMED NAME: RXi Pharmaceuticals Corp DATE OF NAME CHANGE: 20110926 FORMER COMPANY: FORMER CONFORMED NAME: GALENA BIOPHARMA, INC. DATE OF NAME CHANGE: 20110922 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-03-13 0 0001390478 SELLAS Life Sciences Group, Inc. SLS 0001416176 Varian John C/O SELLAS LIFE SCIENCES GROUP, INC. 315 MADISON AVENUE, 4TH FLOOR NEW YORK NY 10017 1 0 0 0 Stock Option (Right to Buy) 5.24 2018-03-13 4 A 0 11000 0.00 A 2028-03-12 Common Stock 11000 11000 D The option shares will vest and became exercisable in equal monthly installments for thirty-six (36) months following the March 13, 2018 grant date, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date. John Varian, by /s/ Ron A. Metzger, Attorney-in-Fact 2018-03-15